The purpose of this study is to assess the safety, effectiveness and tolerability of an investigational cream compared to placebo (inactive substance) over 8 weeks in individuals with scalp and body psoriasis involving at least 10% of scalp and less than 25% of total body.
Men and women aged 12 and older with mild to moderate scalp and body psoriasis may qualify to receive study drug at no cost. There is no cost to participate, and participants will receive compensation for study-related expenses.
Study participation will last 8 weeks and involve 6 visits to the study centre.
Email Tina Craig, Clinical Research Coordinator at DermEffects to register.